Institute for Sexual and Gender Minority Health and Wellbeing, Northwestern University, Chicago, Illinois.
School of Public Health, Georgia State University, Atlanta, Georgia.
J Stud Alcohol Drugs. 2020 Nov;81(6):790-797. doi: 10.15288/jsad.2020.81.790.
Sexual and gender minorities (SGM) are at increased risk for substance use and depression. However, little research has examined the directionality of associations between substance use and depression in this high-risk population, and we are not aware of any to parse associations between depression and changes in the frequency of substance use versus substance use cessation. Such research can help to inform the development of future interventions to address health disparities affecting SGM.
We used data from two longitudinal cohorts of SGM assigned male at birth (SGM-AMAB; N = 1,418) to examine associations between changes in frequency of alcohol, cannabis, and stimulant use and depressive symptoms. Multilevel models tested whether changes in substance use predicted changes in depressive symptoms and vice versa.
Results indicate that when SGM-AMAB decreased their alcohol use or ceased alcohol, cannabis, or stimulant use, they experienced concurrent decreases in depressive symptoms. Only reducing stimulant use (not alcohol or cannabis use) was associated with decreases in depressive symptoms over the subsequent 6 months. Depressive symptoms did not prospectively predict cessation or reduction in the use of any substance.
These findings suggest that clinical interventions targeting substance use may simultaneously reduce depressive symptoms and that reductions in alcohol use (even in the absence of cessation) may simultaneously benefit mental health among SGM-AMAB. The limited evidence of prospective effects over 6 months suggests that studies with shorter lags may be better equipped to examine the directionality of the association between depressive symptoms and substance use/reduction.
性少数群体和跨性别者(SGM)在使用物质和抑郁方面的风险增加。然而,很少有研究调查这个高风险群体中物质使用和抑郁之间关联的方向,我们也不知道有任何研究来分析抑郁与物质使用频率变化或物质使用戒断之间的关联。此类研究有助于为解决影响 SGM 的健康差距制定未来的干预措施提供信息。
我们使用了两个出生时被分配为男性的 SGM 纵向队列的数据(SGM-AMAB;N=1418),以研究酒精、大麻和兴奋剂使用频率变化与抑郁症状之间的关联。多层次模型检验了物质使用的变化是否预测了抑郁症状的变化,反之亦然。
结果表明,当 SGM-AMAB 减少他们的酒精使用或停止酒精、大麻或兴奋剂的使用时,他们同时经历了抑郁症状的减轻。只有减少兴奋剂的使用(而不是酒精或大麻的使用)与随后 6 个月内抑郁症状的减轻有关。抑郁症状并没有前瞻性地预测任何物质的戒断或减少。
这些发现表明,针对物质使用的临床干预措施可能同时减轻抑郁症状,而减少酒精使用(即使没有戒断)也可能同时有益于 SGM-AMAB 的心理健康。6 个月的前瞻性影响的有限证据表明,具有较短滞后的研究可能更适合研究抑郁症状和物质使用/减少之间的关联的方向。